[1] CHANG YL,WU CT,LEE YC.Surgical treatment of synchronous multiple primary lung cancers:experience of 92 patients[J].J Thorac Cardiovasc Surg,2007,134(3):630-637.
[2] HANS B.Multiplicitat von carcinomen bei einem fall von sog."Schneeberger" lungenkrebs mit tuberkulose[J].Virchows Archiv für Pathologische Anatomie und Physiologie und für Klinische Medizin,1924,250(1-2):230-243.
[3] MARTINI N,MELAMED MR.Multiple primary lung cancers[J].The Journal of Thoracic and Cardiovascular Surgery,1975,70(4):606-612.
[4] ANTAKLI T,SCHAEFER RF,RUTHERFORD JE,et al.Second primary lung cancer[J].The Annals of Thoracic Surgery,1995,59(4):863-867.
[5] DETTERBECK FC,LEWIS SZ,DIEKEMPER R,et al.Executive summary:Diagnosis and management of lung cancer,3rd ed:American college of chest physicians evidence-based clinical practice guidelines[J].Chest,2013,143(5 Suppl):7S-37S.
[6] SHEN KR,MEYERS BF,LARNER JM,et al.Special treatment issues in lung cancer[J].Chest,2007,132(3):290S-305S.
[7] 陈亚男,滑炎卿.多原发肺癌HRCT影像特点及其临床意义的研究进展[J].国际医学放射学杂志,2018,41(2):175-179.
CHEN YN,HUA YQ.Research progress in clinical characteristics and HRCT imaging signs of multiple primary lung cancer[J].International Journal of Medical Radiology,2018,41(2):175-179.
[8] ZHANG Y,LI G,LI Y,et al.Imaging features suggestive of multiple primary lung adenocarcinomas[J].Ann Surg Oncol,2020,27(6):2061-2070.
[9] SUH YJ,LEE HJ,SUNG P,et al.A novel algorithm to differentiate between multiple primary lung cancers and intrapulmonary metastasis in multiple lung cancers with multiple pulmonary sites of involvement[J].J Thorac Oncol,2020,15(2):203-215.
[10] SHAO X,NIU R,JIANG Z,et al.Role of PET/CT in management of early lung adenocarcinoma[J].AJR Am J Roentgenol,2020,214(2):437-445.
[11] LIU Y,TANG Y,XUE Z,et al.SUVmax ratio on PET/CT may differentiate between lung metastases and synchronous multiple primary lung cancer[J].Acad Radiol,2020,27(5):618-623.
[12] DETTERBECK FC,BOLEJACK V,ARENBERG DA,et al.The IASLC lung cancer staging project:background data and proposals for the classification of lung cancer with separate tumor nodules in the forthcoming eighth edition of the TNM classification for lung cancer[J].J Thorac Oncol,2016,11(5):681-692.
[13] GIRARD N,DESHPANDE C,LAU C,et al.Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases[J].Am J Surg Pathol,2009,33(12):1752-1764.
[14] LIU M,HE WX,SONG N,et al.Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities[J].Eur J Cardiothorac Surg,2016,50(5):909-913.
[15] MANSUET-LUPO A,BARRITAULT M,ALIFANO M,et al.Proposal for a combined histomolecular algorithm to distinguish multiple primary adenocarcinomas from intrapulmonary metastasis in patients with multiple lung tumors[J].J Thorac Oncol,2019,14(5):844-856.
[16] ONO K,SUGIO K,URAMOTO H,et al.Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins[J].Cancer,2009,115(15):3489-500.
[17] 宋洋,杨笑盈,贾梓淇,等.同期多原发肺癌诊断标准更新与分子遗传学特征研究进展[J].中国胸心血管外科临床杂志,2021,28(3):358-362.
SONG Y,YANG XY,JIA ZQ,et al.Progresses on diagnostic criteria and genetic features of synchronous multiple primary lung cancer[J].Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2021,28(3):358-362.
[18] GOLDSTRAW P,CROWLEY J,CHANSKY K,et al.The IASLC lung cancer staging project:proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours[J].Journal of Thoracic Oncology,2007,2(8):706-714.
[19] DETTERBECK FC,NICHOLSON AG,FRANKLIN WA,et al.The IASLC lung cancer staging project:summary of proposals for revisions of the classification of lung cancers with multiple pulmonary sites of involvement in the forthcoming eighth edition of the TNM classification[J].J Thorac Oncol,2016,11(5):639-650.
[20] JIANG L,HE J,SHI X,et al.Prognosis of synchronous and metachronous multiple primary lung cancers:systematic review and meta-analysis[J].Lung Cancer,2015,87(3):303-310.
[21] ZHAO J,SHEN Z,HUANG Y,et al.Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis[J].BMC Surg,2023,23(1):95.
[22] 陈海泉.多原发非小细胞肺癌的诊断与外科治疗进展[J].中华胸部外科电子杂志,2014,1(01):3-7.
CHEN HQ.Advance on diagnosis and surgical management of multiple primary non-small cell lung cancers[J].Chinese Journal of Thoracic Surgery(Electronic Edition),2014,1(01):3-7.
[23] 王文捷,徐宸桢,高明朗,等.2023年第二版《NCCN肿瘤临床实践指南:非小细胞肺癌》更新解读[J].中国胸心血管外科临床杂志,2023,30(5):660-664.
WANG WJ,XU CZ,GAO ML,et al.Interpretation of the NCCN clinical practice guidelines in oncology for non-small cell lung cancer (version 2.2023) [J].Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023,30(5):660-664.
[24] 王放,岳鹏,苏杭.多原发早期肺癌诊疗专家共识[J].中国胸心血管外科临床杂志,2022,29(12):1545-1553.
WANG F,YUE P,SU H.Expert consensus on the treatment of early-stage multiple primary lung cancers[J].Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2022,29(12):1545-1553.
[25] GINSBERG RJ,RUBINSTEIN LV.Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer[J].The Annals of Thoracic Surgery,1995,60(3):615-623.
[26] SUZUKI K,KOIKE T,ASAKAWA T,et al.A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical Ia lung cancer (Japan Clinical Oncology Group 0201)[J].Journal of Thoracic Oncology,2011,6(4):751-756.
[27] SUZUKI K,WATANABE SI,WAKABAYASHI M,et al.A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer[J].J Thorac Cardiovasc Surg,2022,163(1):289-301 e2.
[28] SAJI H,OKADA M,TSUBOI M,et al.Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L):a multicentre,open-label,phase 3,randomised,controlled,non-inferiority trial[J].The Lancet,2022,399(10335):1607-1617.
[29] NIE Y,WANG X,YANG F,et al.Surgical prognosis of synchronous multiple primary lung cancer:systematic review and Meta-analysis[J].Clin Lung Cancer,2021,22(4):341-350 e3.
[30] LEE DS,LACHAPELLE C,TAIOLI E,et al.Second primary lung cancers demonstrate similar survival with wedge resection and lobectomy[J].Ann Thorac Surg,2019,108(6):1724-1728.
[31] HAN L,GAO S,TAN F,et al.Experience and progress processing policy of simultaneous multiple primary lung cancer[J].Chin J Lung Cancer,2018,21(3):180-184.
[32] 屈日荣,郝志鹏,彭澍,等.同期双侧单孔胸腔镜切除肺多发磨玻璃影的单中心经验[J].中国胸心血管外科临床杂志,2020,27(8):948-952.
QU RR,HAO ZP,PENG S,et al.Simultaneous bilateral single-incision thoracoscopic resection for multiple ground-glass opacity lesions in the lung:a single-center experience[J].Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2020,27(8):948-952.
[33] ZHANG Y,WANG Y,LV C,et al.Clinical analysis of 56 cases of simultaneous bilateral video-assisted thoracoscopic surgery for bilateral synchronous multiple primary lung adenocarcinoma[J].J Thorac Dis,2018,10(12):6452-6457.
[34] GUO H,MAO F,ZHANG H,et al.Analysis on the prognostic and survival factors of synchronous multiple primary lung cancer[J].Chin J Lung Cancer,2017,20(1):21-27.
[35] ZHANG R,WANG G,LIN Y,et al.Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer:a population-based study[J].Transl Lung Cancer Res,2020,9(1):33-44.
[36] BAIG MZ,RAZI SS,STROEVER S,et al.Anatomic resection has superior long-term survival compared with wedge resection for second primary lung cancer after prior lobectomy[J].Eur J Cardiothorac Surg,2021,59(5):1014-1020.
[37] 沈涛,卢珠明,段楚骁,等.同时性多原发肺癌淋巴结转移规律的临床研究[J].岭南现代临床外科,2021,21(5):561-565.
SHEN T,LU ZM,DUAN CX,et al.Lymph node metastasis of simultaneous multiple primary lung cancer[J].Lingnan Modern Clinics in Surgery,2021,21(5):561-565.
[38] OKADA M,SAKAMOTO T,YUKI T,et al.Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer[J].Ann Thorac Surg,2006,81(3):1028-1032.
[39] ZHANG Y,DENG C,ZHENG Q,et al.Selective mediastinal lymph node dissection strategy for clinical T1N0 invasive lung cancer:A prospective,multicenter,clinical trial[J].Journal of Thoracic Oncology,2023,18(7):931-939.
[40] 樊化,孙萍,巫开文,等.CT联合血清CEA、NSE、Cyfra21-1对非小细胞肺癌纵隔淋巴结转移的预测价值[J].山东医药,2022,62(7):57-60.
FAN H,SUN P,WU KW,et al.The predictive value of CT combined with serum CEA,NSE,and Cyfra21-1 for mediastinal lymph node metastasis in non-small cell lung cancer[J].Shandong Medical Journal,2022,62(7):57-60.